Letters Inhaled corticosteroids for COPD

Addition of long acting β agonist is not supported by clinical trial evidence

BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e8361 (Published 20 December 2012) Cite this as: BMJ 2012;345:e8361
  1. J R Manderville, pharmacist1
  1. 1Medical Teaching Unit, QE II Health Sciences Centre, Halifax, NS, Canada B3H 3A7
  1. John.manderville{at}cdha.nshealth.ca

Park and colleagues’ statement that the role of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD) is controversial may well be an understatement.1 2 3 However, their recommendation to add a long acting β agonist to …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe